Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection

American Journal of Health-System Pharmacy

Volumn 70, Issue 15, 2013, Pages 1336-1341

  Preslaski, Candice R ^a   Mueller, Scott W ^b   Wempe, Michael F ^b   MacLaren, Robert ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; POLYVINYLCHLORIDE; SODIUM CHLORIDE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; DRUG DEGRADATION; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LAMINAR AIRFLOW; PHARMACIST; PHOTOCHEMISTRY; CHEMISTRY; DRUG FORMULATION; DRUG PACKAGING; DRUG STORAGE; INJECTION; MASS FRAGMENTOGRAPHY; PH; PROCEDURES; TANDEM MASS SPECTROMETRY; TIME;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXMEDETOMIDINE; DRUG COMPOUNDING; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HYDROGEN-ION CONCENTRATION; INJECTIONS; POLYVINYL CHLORIDE; SODIUM CHLORIDE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84894332226     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp120390     Document Type: Article

References (15)

1. Precedex (dexmedetomidine hydrochloride injection) package insert. www.precedex.com (accessed 2011 Feb 24).
2. Hospira. Dosing guidelines for Precedex: nonintubated procedural sedation and ICU sedation. www.precedex.com/dosing (accessed 2011 Feb 24).
3. Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother. 2004; 38:1130-5.
4. Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009; 43:2064-74.
5. Popat K, Purugganan R, Malik I. Off-label uses of dexmedetomidine. Adv Anesth. 2006; 21:177-92.
6. Shehabi Y, Botha JA, Ernest D et al. Clinical application, the use of dexmedetomidine in intensive care sedation. Crit Care Shock. 2010; 13:40-50.
7. Guinter JR, Kristeller JL. Prolonged infusions of dexmedetomidine in critically ill patients. Am J Health-Syst Pharm. 2010; 67:1246-53.
8. Wunsch H, Kahn JM, Kramer AA et al. Dexmedetomidine in the care of critically ill patients from 2001 to 2007. Anesthesiology. 2010; 113:386-94.
9. Ruokonen E, Parviainen I, Jakob SM et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med. 2009; 35:282-90.
10. Pandharipande PP, Pun BT, Herr DL et al. Effect of sedation with dexmedetomidine vs. lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007; 298:2644-53.
11. Riker RR, Shehabi Y, Bokesch PM et al. Dexmedetomidine vs. midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009; 301:489-99.
12. Jakob SM, Ruokonen E, Grounds RM et al. Dexmedetomidine vs. midazolam or propofol for sedation during prolonged mechanical ventilation. Two randomized controlled trials. JAMA. 2012; 307:1151-60.
13. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med. 2010; 36:926-39.
14. Pharmaceutical compounding - sterile preparations (general information chapter 797). In: The United States pharmacopeia, 27th rev., and The national formulary, 22nd ed. Rockville, MD: United States Pharmacopeial Convention; 2004:2350-70.
15. United States Pharmacopeial Convention. Particulate matter in injections (general information chapter 788). www.usp.org.pdf/EN/USPNF/788particulatematter.pdf (accessed 2011 Feb 22).